Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer

Fig. 4

ROC curve analyses using CPT1A to differentiate breast cancer from benign breast disease or healthy controls. a ROC curves of CPT1A for breast cancer patients versus healthy controls in the training set (left) and test set (right), respectively. b ROC curves of CPT1A for breast cancer patients versus benign breast cancer patients in the training set (left) and test set (right), respectively. c ROC curves of CPT1A for TNBC patients versus healthy controls in the training set (left) and test set (right), respectively

Back to article page